EFFICACY AND SAFETY OF APIXABAN COMPARED TO WARFARIN FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN 18,201 PATIENTS WITH ATRIAL FIBRILLATION: PRIMARY RESULTS OF THE ARISTOTLE TRIAL

被引：2
|
作者：
Ezekowitz, J.
Dorian, P.
Granger, C.
Alexander, J.
Lopes, R.
Hanna, M.
Geraldes, M.
Wallentin, L.
机构：
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2011年 / 27卷 / 05期
关键词：
D O I：
10.1016/j.cjca.2011.07.611
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S334 / S334
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
    Lee, Soyon
    Anglade, Moise W.
    Meng, Joy
    Hagstrom, Kelly
    Kluger, Jeffrey
    Coleman, Craig I.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (04): : 472 - 479
  • [42] Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
    Guimaraes, Patricia O.
    Pokorney, Sean D.
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Gersh, Bernard J.
    Giczewska, Anna
    Carnicelli, Anthony
    Lewis, Basil S.
    Hanna, Michael
    Wallentin, Lars
    Vinereanu, Dragos
    Alexander, John H.
    Granger, Christopher B.
    CLINICAL CARDIOLOGY, 2019, 42 (05) : 568 - 571
  • [43] APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL
    Guimaraes, Patricia
    Alexander, John
    Wojdyla, Daniel
    Thomas, Laine
    Alings, Marco
    Flaker, Greg
    Al-Khatib, Sana
    Hanna, Michael
    Wallentin, Lars
    Granger, Christopher
    Lopes, Renato
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 691 - 691
  • [44] Apixaban versus warfarin in Patients with Atrial Fibrillation in relation to Prior Warfarin Use: Insights from the ARISTOTLE trial
    Garcia, David A.
    Alexander, John H.
    Lopes, Renato D.
    Thomas, Laine
    Yang, Hongqiu
    Ansell, Iack
    Commerford, Patrick
    Flaker, Greg
    Lanas, Fernando
    Mohan, Puneet
    Vinereanu, Dragos
    Xavier, Denis
    Granger, Christopher
    Wallentin, Lars
    CIRCULATION, 2012, 126 (21)
  • [45] Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial
    Al-Khatib, Sana M.
    Thomas, Laine
    Wallentin, Lars
    Lopes, Renato D.
    Gersh, Bernard
    Garcia, David
    Ezekowitz, Justin
    Alings, Marco
    Yang, Hongqui
    Alexander, John H.
    Flaker, Gregory
    Hanna, Michael
    Granger, Christopher B.
    EUROPEAN HEART JOURNAL, 2013, 34 (31) : 2464 - 2471
  • [46] Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (vol 4, e002015, 2015)
    Rao, M. P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (04):
  • [47] Phase III trial shows apixaban significantly reduces the risk of stroke or systemic embolism compared with warfarin
    Granger, Christopher B.
    FUTURE CARDIOLOGY, 2011, 7 (06) : 730 - 731
  • [48] Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
    Piccini, Jonathan P.
    Hellkamp, Anne S.
    Washam, Jeffrey B.
    Becker, Richard C.
    Breithardt, Guenter
    Berkowitz, Scott D.
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Hacke, Werner
    Mahaffey, Kenneth W.
    Nessel, Christopher C.
    Singer, Daniel E.
    Fox, Keith A. A.
    Patel, Manesh R.
    CIRCULATION, 2016, 133 (04) : 352 - 360
  • [49] Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial (vol 11, pg 503, 2012)
    Easton, J. D.
    Lopes, R. D.
    Bahit, M. C.
    LANCET NEUROLOGY, 2012, 11 (12): : 1021 - 1021
  • [50] Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
    Skjoth, Flemming
    Larsen, Torben Bjerregaard
    Rasmussen, Lars Hvilsted
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 981 - 988
12345